Advising Rexam, the leading global beverage can maker, on global merger control aspects of the $6.9bn takeover by US rival Ball Corporation, which brought together the world’s two largest producers of beverage cans.
Advising Novartis on its joint venture with GlaxoSmithKline's to create a world-leading consumer healthcare business.
Advising Johnson & Johnson on various transactions on an ongoing basis, including its $6.5bn acquisition of Momenta Pharmaceuticals Inc.; its $30bn acquisition of Swiss biotech company Actelion Pharmaceuticals; its $3.3bn acquisition of hair-products company Vogue International; its $4bn sale of Ortho Clinical Diagnostics, a leading diagnostic technology and manufacturing company; its $1.2bn acquisition of Aragon Pharmaceuticals; and collaboration and licensing agreements with MacroGenics and Achillion Pharmaceuticals for various biopharmaceutical compounds.
Advising Hamakua Energy Partners, a subsidiary of Arclight Capital Partners, against Plaintiff Hu Honua Bioenergy’s Section 1 and state antitrust law claims of an illegal agreement to terminate Hu Honua’s power purchase agreement with the power grid operator in the District of Hawaii.
Advising a global investment bank in a collection of regulatory and criminal investigations into allegations of a conspiracy among the world’s largest banks to manipulate the setting of the Libor and other leading benchmark interest rates.